Early infant diagnosis (EID) of HIV in infants provides an opportunity for early 31 detection of the infection and early access to Antiretroviral treatment (ART). Dried Blood Spot 32 (DBS) samples are used for EID of HIV-exposed infants, born from HIV positive mothers. 33 However, DBS rejection rates have been exceeding in Zimbabwe the target of less than 2% per 34 month set by the National Microbiology Reference Laboratory (NMRL). The aim of this study 35 was to determine the DBS samples rejection rate, the reasons for rejection and the possible 36 associations between rejection and level of health facility where the sample was collected.
The laboratory rejects all samples that do not meet the criteria indicated in Box 1.
80 Figure 1 below shows the DBS samples that were being accepted for testing, anything that was 81 not meeting this criteria in terms of volume was being rejected. 84 There is evidence that insufficient specimen volume is one of the major reasons for high 85 proportion of DBS rejections. It is unclear why that is a case, given that the evidence also 86 suggests that the technology used for testing DBS samples can analyse and produce conclusive 87 results from samples with minimum of two full spots [6] . The implication of this is that EID-88 eligible infants may miss diagnostic opportunities (MDO) due to DBS [9] . The same stuy also showed that DBS collected at primary and 100 secondary health care facilities were two to three times more likely to be rejected than those 101 collected at tertiary healthcare facilities [10].
Figure 1: Sufficient dried blood spot

102
In Zimbabwe, it takes up to fourteen days from sample collection before NMRL communicates 103 rejection to the submitting healthcare facility [11] . It takes further few weeks before the 104 healthcare facility informs the mother-baby pair that the sample has been rejected and that There have been concerns that there is no laboratory surveillance in Zimbabwe to monitor and 109 track EID related processes from pre-analytical phase of laboratory processes. In addition, there 110 are very few studies that investigate the causes of DBS rejections [6] . The absence of the data on DBS rejection rates means that there is a limited intelligence to act and take appropriate 112 corrective actions to improve the EID program and reduce loss to follow up.
113
The aim of this study was to determine the proportion of DBS samples that were sent to the 114 Zimbabwean NMRL and rejected between January 2017 and December 2017 and the reasons for 115 their rejection.
116
METHODS
117
Study Design
118
A cross-sectional study that used routine data from EID laboratory information management 119 system (LIMS). DBS samples collected from all the facilities from five provinces of Zimbabwe 120 referred to NMRL were logged into EID laboratory information system (LIMS). Records on 121 rejected samples in the EID LIMS were validated against source hard copy documents.
122
Descriptive analysis was performed to describe the variables in relation to number and 123 proportion of rejected DBS, reasons for rejection and levels of health facility.
124
Study Setting
125
General setting: 126 Zimbabwe is a country in Southern Africa, with a population of 17 million people in 2017 [11] .
127
The country is divided into 8 provinces and 2 metropolitan provinces (Bulawayo and Harare). (1) 10 (1) 0 (0) 0 (0) 1 (8) Mismatch information 52 (4) 42 (4) 10 (7) 0 (0) 0 (0) Cross contamination 75 (6) 71 (7) 4 (3) 0 (0) 0 (0) laboratory request forms resulted in reduction in errors from 19.05% to 6.76% [13] .
252
The current study found that large proportion of rejection were due to insufficient blood volume 253 collection. and actions could be taken at district level before sending the samples to the NMRL.
301
 Laboratory processes needs to strengthen implementation of quality management system 302 to identify deficiencies in DBS sample management so that corrective actions are taken to 303 continuously reduce sample rejection rates that impacts patient care.
304
 NMRL needs to conduct a laboratory validation of "two insufficient spot protocol" 305 against a" one full spot protocol" so that the rejection criteria may be reviewed based on 306 the scientific evidence of the validation. This study has shown that DBS rejection rates were above the national target. The major reason 310 for rejection was insufficient volume samples. Clinic/rural health centers have higher rejection 311 rate than central hospitals. Over all, there is need to monitor rejection rates in real time, so that 312 corrective and preventive actions may be taken to reduce or eliminate causes of DBS rejection. 
